Stockreport

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion [CNBC]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead Sciences said on Monday it ?will buy cancer therapy partner Arcellx for an implied equity ?value of $7.8 ?billion, expanding ?their cell therapy development coll [Read more]